ENTERO Stock Overview
Engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ENTERO from our risk checks.
Entero Healthcare Solutions Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,224.65 |
| 52 Week High | ₹1,265.00 |
| 52 Week Low | ₹970.00 |
| Beta | 0 |
| 11 Month Change | 7.77% |
| 3 Month Change | 19.86% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 6.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| ENTERO | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -2.8% | 0.5% | 1.1% |
| 1Y | n/a | 44.6% | 41.6% |
Return vs Industry: Insufficient data to determine how ENTERO performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how ENTERO performed against the Indian Market.
Price Volatility
| ENTERO volatility | |
|---|---|
| ENTERO Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: ENTERO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ENTERO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 3,240 | Prabhat Agrawal | www.enterohealthcare.com |
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India. The company is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. It also offers nebulizers, digital thermometers, blood pressure monitors, and adult diapers.
Entero Healthcare Solutions Limited Fundamentals Summary
| ENTERO fundamental statistics | |
|---|---|
| Market cap | ₹53.70b |
| Earnings (TTM) | ₹397.99m |
| Revenue (TTM) | ₹39.22b |
133.8x
P/E Ratio1.4x
P/S RatioIs ENTERO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENTERO income statement (TTM) | |
|---|---|
| Revenue | ₹39.22b |
| Cost of Revenue | ₹35.74b |
| Gross Profit | ₹3.48b |
| Other Expenses | ₹3.08b |
| Earnings | ₹397.99m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 16, 2024
| Earnings per share (EPS) | 9.15 |
| Gross Margin | 8.87% |
| Net Profit Margin | 1.01% |
| Debt/Equity Ratio | 16.8% |
How did ENTERO perform over the long term?
See historical performance and comparison